MEDIUM OPTIMIZATION FOR ISOFLAVONE AGLYCONES PRODUCTION FROM FERMENTED DEFATTED SOYBEAN FLOUR BY DISPLAY OF Β-GLUCOSIDASE FROM BACILLUS LICHENIFORMIS NRC24 AND EVALUATION OF THEIR ANTIVIRAL AND ANTITUMOR ACTIVITIES
DOI:
https://doi.org/10.55251/jmbfs.5713Keywords:
Bacillus licheniformis, β-glucosidase, daidzein, genistein, optimizationAbstract
The submerged fermentation parameters of defatted soybean flour with Bacillus licheniformis NRC24 were optimized using the one-factor at-a-time method and Box-Behnken design to maximize the production of β-glucosidase and transformation of glucosidic isoflavones (daidzin and genistin) into their aglycones. One-factor-at-a-time optimization studies revealed that 80 g/L of defatted soybean flour , fermentation time of 16 h, temperature at 37°C, initial pH value of 7, inoculum volume of 5% (6x107 CFU/mL), and medium volume of 50 mL in 250 mL Erlenmeyer flask with shaking conditions at 100 rpm were the most suitable conditions for aglycones production. The addition of cellobiose (1 percent w/v) to the soy flour medium resulted in a significantly increase in total aglycone. Further optimization using the Box-Behnken design resulted in a 1.11-fold increase in daidzein and genistein. Antiviral activity was observed against the (H5N1) influenza, herpes simplex type 1, and rota virus. The MTT cytotoxicity assay of the extract using MDCK, Vero, and MA104 cell lines revealed that fermented soybean flour reduced cytotoxicity more than the unfermented one. However, it showed higher cytotoxicity against HCT-116 colon cancer cells, MCF-7 breast and PC3 prostate cancer cells than the unfermented soy extract.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asmaa I. El-Shazly, Azza M. Noor El-Deen, Nayera A.M. Abdelwahed, Yousseria M. Shetaia, Nevin A. Ibrahim, Mohamed A. Farid
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).